Marco Presta
#141,932
Most Influential Person Now
Italian biologist and researcher
Marco Presta's AcademicInfluence.com Rankings
Marco Prestabiology Degrees
Biology
#10107
World Rank
#13403
Historical Rank
Molecular Biology
#1437
World Rank
#1464
Historical Rank
Download Badge
Biology
Marco Presta's Degrees
- Bachelors Biology University of Milan
- Masters Biotechnology University of Milan
Similar Degrees You Can Earn
Why Is Marco Presta Influential?
(Suggest an Edit or Addition)Marco Presta's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. (2005) (1225)
- Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans* (2001) (707)
- Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. (1999) (649)
- Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. (1999) (383)
- Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration. (1986) (353)
- Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. (2005) (273)
- Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration (1986) (271)
- Mammalian tumor xenografts induce neovascularization in zebrafish embryos. (2007) (265)
- Human Erythropoietin Induces a Pro-Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo (1999) (262)
- Both normal and tumor cells produce basic fibroblast growth factor (1986) (252)
- The zebrafish/tumor xenograft angiogenesis assay (2007) (243)
- Nerve growth factor–endothelial cell interaction leads to angiogenesis in vitro and in vivo (2002) (238)
- The gelatin sponge–chorioallantoic membrane assay (2006) (236)
- New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay. (1997) (233)
- Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. (1997) (225)
- Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. (1993) (218)
- Interaction of HIV-1 Tat Protein with Heparin (1997) (194)
- Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. (2004) (179)
- Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2. (2010) (178)
- HIV-tat protein is a heparin-binding angiogenic growth factor. (1996) (175)
- Role of the soluble pattern recognition receptor PTX3 in vascular biology (2007) (174)
- Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. (2003) (172)
- Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. (1995) (158)
- Erythropoietin as an angiogenic factor (2003) (152)
- Inhibition of Angiogenesis and Tumor Growth by SCH221153, a Dual αvβ3 and αvβ5 Integrin Receptor Antagonist (2001) (147)
- αvβ3 Integrin Mediates the Cell-adhesive Capacity and Biological Activity of Basic Fibroblast Growth Factor (FGF-2) in Cultured Endothelial Cells (1997) (141)
- Generation of Biologically Active Angiostatin Kringle 1–3 by Activated Human Neutrophils1 (2002) (140)
- Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. (2007) (138)
- Osteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis1 (2003) (135)
- Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form (1989) (133)
- Cutting Edge: Proangiogenic Properties of Alternatively Activated Dendritic Cells1 (2005) (131)
- Dendritic cell-endothelial cell cross-talk in angiogenesis. (2007) (131)
- Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach. (2017) (131)
- Fibroblast Growth Factor Receptor-1 Is Essential for In Vitro Cardiomyocyte Development (2003) (129)
- Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine1 (2006) (128)
- The mitogenic signaling pathway but not the plasminogen activator- inducing pathway of basic fibroblast growth factor is mediated through protein kinase C in fetal bovine aortic endothelial cells (1989) (128)
- Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. (2007) (126)
- Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. (1997) (125)
- Multiple Interactions of HIV-I Tat Protein with Size-defined Heparin Oligosaccharides* (1999) (123)
- Inflammatory cells and chemokines sustain FGF2-induced angiogenesis. (2009) (120)
- Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. (1996) (119)
- Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans (1996) (119)
- Shedding of Membrane Vesicles Mediates Fibroblast Growth Factor-2 Release from Cells* (2003) (115)
- The Basic Domain in HIV-1 Tat Protein as a Target for Polysulfonated Heparin-mimicking Extracellular Tat Antagonists* (1998) (112)
- Antiangiogenic and Vascular-Targeting Activity of the Microtubule-Destabilizing trans-Resveratrol Derivative 3,5,4′-Trimethoxystilbene (2005) (111)
- Identification of an Antiangiogenic FGF2-binding Site in the N Terminus of the Soluble Pattern Recognition Receptor PTX3* (2006) (109)
- HIV-1 Tat protein and endothelium: From protein/cell interaction to AIDS-associated pathologies (2004) (108)
- Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2 (2002) (107)
- Cutting Edge: IL-1β Mediates the Proangiogenic Activity of Osteopontin-Activated Human Monocytes1 (2006) (105)
- The discovery of angiogenic factors: a historical review. (2000) (104)
- A form of human basic fibroblast growth factor with an extended amino terminus. (1987) (101)
- Response to Comment on “Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine” (2006) (101)
- Heparin derivatives as angiogenesis inhibitors. (2003) (97)
- Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis (1998) (96)
- The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor. (1997) (96)
- Sex hormones modulate the synthesis of basic fibroblast growth factor in human endometrial adenocarcinoma cells: Implications for the neovascularization of normal and neoplastic endometrium (1988) (94)
- Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy. (2015) (93)
- Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts. (1995) (89)
- Role of soluble mediators in angiogenesis. (1996) (88)
- Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds. (1999) (88)
- Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: Role of the low affinity heparin‐like bFGF receptors (1993) (87)
- αvβ3 integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells (2001) (85)
- The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies. (2007) (83)
- A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. (1991) (83)
- Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. (2001) (82)
- Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1. (1994) (82)
- Undersulfated and glycol-split heparins endowed with antiangiogenic activity. (2004) (80)
- Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2. (2003) (78)
- The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis (2015) (76)
- Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process. (1999) (75)
- Pentraxin 3 Inhibits Fibroblast Growth Factor 2–Dependent Activation of Smooth Muscle Cells In Vitro and Neointima Formation In Vivo (2005) (74)
- Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. (1999) (73)
- The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo (2011) (73)
- Zebrafish embryo, a tool to study tumor angiogenesis. (2011) (73)
- Cell-Mediated Delivery of Fibroblast Growth Factor-2 and Vascular Endothelial Growth Factor onto the Chick Chorioallantoic Membrane: Endothelial Fenestration and Angiogenesis (2001) (73)
- Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors. (2002) (71)
- A pro‐inflammatory signature mediates FGF2‐induced angiogenesis (2009) (71)
- Interaction of high‐molecular‐weight basic fibroblast growth factor with endothelium: Biological activity and intracellular fate of human recombinant Mr 24,000 bFGF (1994) (71)
- Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts (2002) (70)
- In vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2. (1999) (70)
- Fibroblast growth factor 2‐induced angiogenesis in zebrafish: the zebrafish yolk membrane (ZFYM) angiogenesis assay (2009) (69)
- Non-peptidic Thrombospondin-1 Mimics as Fibroblast Growth Factor-2 Inhibitors (2010) (69)
- Pentosan Polysulfate as an Inhibitor of Extracellular HIV-1 Tat* (2001) (68)
- Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications (2019) (67)
- Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. (2016) (66)
- In vitro and ex vivo retina angiogenesis assays (2014) (65)
- Nuclear localization of endogenous basic fibroblast growth factor in cultured endothelial cells. (1991) (65)
- Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. (1991) (64)
- Long Pentraxin 3/Tumor Necrosis Factor-Stimulated Gene-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis (2012) (63)
- Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors. (2002) (62)
- Future applications of FGF/FGFR inhibitors in cancer (2018) (62)
- Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. (2009) (62)
- Heparin Octasaccharides Inhibit Angiogenesis In vivo (2005) (61)
- alphavbeta3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells. (1997) (60)
- Biological and molecular properties of a new αvβ3/αvβ5 integrin antagonist (2005) (60)
- Long pentraxin‐3 as an epithelial–stromal fibroblast growth factor‐targeting inhibitor in prostate cancer (2013) (60)
- Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors. (2001) (59)
- Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist. (2001) (59)
- Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain. (2008) (58)
- Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells (2013) (58)
- Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells (2003) (57)
- Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist. (2004) (57)
- Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin (2011) (57)
- Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells (2001) (57)
- Purification of basic fibroblast growth factor from rat brain: identification of a Mr 22,000 immunoreactive form. (1988) (56)
- Basic fibroblast growth factor: Production, mitogenic response, and post‐receptor signal transduction in cultured normal and transformed fetal bovine aortic endothelial cells (1989) (56)
- Zebrafish embryo as a tool to study tumor/endothelial cell cross-talk. (2013) (56)
- Long pentraxin 3: A novel multifaceted player in cancer. (2018) (56)
- Thrombospondin‐1 inhibits Kaposi's sarcoma (KS) cell and HIV‐1 Tat‐induced angiogenesis and is poorly expressed in KS lesions (1999) (52)
- Biotechnological engineering of heparin/heparan sulphate: a novel area of multi-target drug discovery. (2005) (51)
- Recombinant human erythropoietin induces intussusceptive microvascular growth in vivo (2004) (51)
- HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium. (2009) (50)
- Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV‐1 Tat protein antagonists (2004) (49)
- Multiple forms of an angiogenesis factor: basic fibroblast growth factor. (1988) (49)
- Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2 (2018) (49)
- Transcriptional and posttranscriptional regulation of urokinase‐type plasminogen activator expression in endothelial cells by basic fibroblast growth factor (1995) (48)
- Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study. (1998) (47)
- Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone–Regulated Tumors (2011) (47)
- αvβ3-integrin-dependent activation of focal adhesion kinase mediates NF-κB activation and motogenic activity by HIV-1 Tat in endothelial cells (2005) (47)
- Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans. New insights from trypsin digestion studies. (1993) (46)
- Promotion of tumour metastases and induction of angiogenesis by native HIV‐1 Tat protein from BK virus/tat transgenic mice (1996) (46)
- Role of endothelial cell extracellular signal-regulated kinase1/2 in urokinase-type plasminogen activator upregulation and in vitro angiogenesis by fibroblast growth factor-2. (1999) (46)
- Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells (1995) (46)
- Quantification of damage to striated muscle after normothermic or hypothermic ischemia. (1981) (45)
- Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir. (2001) (45)
- Role of fibroblast growth factor-2 in human brain: a focus on development (2000) (45)
- Involvement of αvβ3 integrin in gremlin-induced angiogenesis (2012) (44)
- Activation of endothelial cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat protein. (2001) (44)
- Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium. (1990) (43)
- A distinct basic fibroblast growth factor (FGF-2)/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells. (1996) (43)
- Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey. (2006) (43)
- The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo (2010) (43)
- αvβ3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers (2008) (43)
- Calcitonin receptor-like receptor guides arterial differentiation in zebrafish. (2008) (42)
- Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide (2009) (42)
- Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR (2013) (41)
- Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action. (1995) (40)
- Integrin &agr;V&bgr;3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo (2005) (40)
- SIGMAR1 Regulates Membrane Electrical Activity in Response to Extracellular Matrix Stimulation to Drive Cancer Cell Invasiveness. (2016) (40)
- Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor‐2 (1999) (39)
- Modulation of Angiogenesis by a Tetrameric Tripeptide That Antagonizes Vascular Endothelial Growth Factor Receptor 1* (2008) (39)
- Cyclic Adenosine Monophosphate-Response Element–Binding Protein Mediates the Proangiogenic or Proinflammatory Activity of Gremlin (2014) (38)
- Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease (2015) (38)
- Characterization of a Mr 25,000 basic fibroblast growth factor form in adult, regenerating, and fetal rat liver. (1989) (38)
- Modulation of plasminogen activator activity in human endometrial adenocarcinoma cells by basic fibroblast growth factor and transforming growth factor beta. (1988) (38)
- Gene expression profile in fibroblast growth factor 2-transformed endothelial cells (2002) (37)
- alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells. (2001) (37)
- Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor. (1994) (37)
- Angiopoietin-1 mediates the proangiogenic activity of the bone morphogenic protein antagonist Drm. (2008) (37)
- High molecular weight immunoreactive basic fibroblast growth factor-like proteins in rat pituitary and brain (1988) (36)
- Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule (2012) (36)
- Antiangiogenic Activity of Semisynthetic Biotechnological Heparins: Low-Molecular-Weight–Sulfated Escherichia coli K5 Polysaccharide Derivatives as Fibroblast Growth Factor Antagonists (2004) (36)
- Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform (2020) (35)
- Integrin alphavbeta3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivo. (2005) (34)
- Human iPSC modelling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes (2019) (34)
- Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region. (1992) (34)
- Differential expression of fibroblast growth factor receptors by human neurones, astrocytes, and microglia (1994) (33)
- Synthesis of Urokinase‐Type Plasminogen Activator and of Type‐ 1 Plasminogen Activator Inhibitor in Neuronal Cultures of Human Fetal Brain: Stimulation by Phorbol Ester (1990) (33)
- Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis. (1999) (33)
- TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis (2013) (33)
- Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross‐talk in the bone marrow of multiple myeloma patients (2013) (33)
- Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. (2012) (33)
- The role of fibroblast growth factor‐2 in the vascularization of the chick embryo chorioallantoic membrane (2002) (32)
- Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): Identification of two Asp‐Gly‐Arg‐Containing domains involved in the mitogenic activity of bFGF in endothelial cells (1991) (32)
- Role of basic fibroblast growth factor in the formation of the capillary plexus in the chick embryo chorioallantoic membrane. An in situ hybridization, immunohistochemical and ultrastructural study. (1998) (32)
- Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases. (2016) (32)
- Basic fibroblast growth factor in human pheochromocytoma: A biochemical and immunohistochemical study (1993) (32)
- New aspects of blood vessel growth: tumor and tissue-derived angiogenesis factors. (1988) (31)
- Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case. (2009) (31)
- Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy. (2013) (30)
- Fibroblast growth factor-2 antagonist and antiangiogenic activity of long-pentraxin 3-derived synthetic peptides. (2009) (30)
- Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy (2017) (30)
- Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy. (2015) (30)
- Endogenous and exogenous fibroblast growth factor-2 modulate wound healing in the chick embryo chorioallantoic membrane (2004) (30)
- N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors (2018) (30)
- Thrombospondin‐1/HIV‐1 Tat protein interaction: modulation of the biological activity of extracellular Tat (2000) (29)
- Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist (2016) (29)
- Osteopontin Overexpression Inhibits in Vitro Re-endothelialization via Integrin Engagement* (2007) (29)
- Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis (2017) (28)
- Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action (2010) (28)
- A novel ex vivo murine retina angiogenesis (EMRA) assay. (2013) (28)
- Clinical studies with angiogenesis inhibitors: biological rationale and challenges for their evaluation. (1996) (28)
- Dendritic cells in inflammatory angiogenesis and lymphangiogenesis. (2018) (28)
- Basic fibroblast growth factor in neuronal cultures of human fetal brain (1990) (27)
- Antiangiogenic Activity of a Neutralizing Human Single-Chain Antibody Fragment against Fibroblast Growth Factor Receptor 1 (2010) (27)
- The nanostructured secretome. (2019) (27)
- Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer (2017) (27)
- Sphingosine-1-Phosphate Receptor-1 Controls Venous Endothelial Barrier Integrity in Zebrafish (2012) (26)
- VEGFR2 activation mediates the pro-angiogenic activity of BMP4 (2019) (26)
- Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors. (2016) (26)
- Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance. (2015) (26)
- Biosafe inertization of municipal solid waste incinerator residues by COSMOS technology. (2014) (26)
- FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress (2020) (25)
- Estro-progestinic replacement therapy modulates the levels of basic fibroblast growth factor (bFGF) in postmenopausal endometrium. (1993) (25)
- Liver tumors induced by a new beta-adrenoreceptor blocking agent in female rats. (1982) (25)
- Role of nanomechanics in canonical and noncanonical pro-angiogenic ligand/VEGF receptor-2 activation. (2012) (25)
- Molecular cloning and knockdown of galactocerebrosidase in zebrafish: new insights into the pathogenesis of Krabbe's disease. (2014) (24)
- alpha(v)beta3-integrin-dependent activation of focal adhesion kinase mediates NF-kappaB activation and motogenic activity by HIV-1 Tat in endothelial cells. (2005) (24)
- HIV-1 Tat protein: a target for the development of anti-AIDS therapies (2002) (24)
- The NH2-terminal extension of high molecular weight forms of basic fibroblast growth factor (bFGF) is not essential for the binding of bFGF to nuclear chromatin in transfected NIH 3T3 cells. (1993) (24)
- Human placental tissue stimulates bovine capillary endothelial cell growth, migration and protease production (1985) (24)
- A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers (2015) (24)
- Anti-angiogenic activity of the purine analog 6-thioguanine (2002) (23)
- Angiostatic, tumor inflammatory and anti-tumor effects of CXCL447–70 and CXCL4L147–70 in an EGF-dependent breast cancer model (2014) (23)
- Characterization of a Mr 20,000 basic fibroblast growth factor-like protein secreted by normal and transformed fetal bovine aortic endothelial cells. (1990) (23)
- Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle (1998) (22)
- Endothelial cells overexpressing basic fibroblast growth factor (FGF-2) induce vascular tumors in immunodeficient mice (2004) (22)
- Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells. (1997) (22)
- Total reflection X‐Ray fluorescence spectroscopy to study Pb and Zn accumulation in zebrafish embryos (2015) (22)
- The Thymidine Phosphorylase Inhibitor 5′-O-Tritylinosine (KIN59) Is an Antiangiogenic Multitarget Fibroblast Growth Factor-2 Antagonist (2012) (20)
- Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy (2015) (20)
- In vitro and in vivo DNA damage of male and female rat liver nuclei by oncogenic and nononcogenic beta blockers. (1983) (20)
- Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth (2018) (19)
- Decrease of the activity of the mixed function oxidase system in regenerating rat liver: an alternative explanation. (1980) (19)
- Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity (2009) (19)
- Up-regulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx. (1996) (19)
- Evaluation of the tumor-promoting activity of two beta-adrenoreceptor blocking agents, propranolol and atenolol, in liver of Fischer 344 rats. (1994) (19)
- Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression (2019) (18)
- Inhibition of angiogenesis in rats by IL-1 receptor antagonist and selected cytokine antibodies (1994) (18)
- Impact of VEGF‐dependent tumour micro‐environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice (2009) (17)
- The FGF/FGFR System in the Physiopathology of the Prostate Gland. (2020) (17)
- Cerebellar vermis hypoplasia in a case of cri-du-chat syndrome. (1993) (17)
- 3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy (2017) (17)
- Subcellular localization and biological activity of M(r) 18,000 basic fibroblast growth factor: site-directed mutagenesis of a putative nuclear translocation sequence. (1993) (17)
- Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress (2020) (16)
- Characterization of the effects of two polysulfonated distamycin A derivatives, PNU145156E and PNU153429, on HIV type 1 Tat protein. (1998) (15)
- Noncompetitive, Chemokine-mediated Inhibition of Basic Fibroblast Growth Factor-induced Endothelial Cell Proliferation* (1998) (15)
- The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach (2019) (14)
- Regulated expression pattern of gremlin during zebrafish development. (2005) (14)
- Endothelial cell dysfunction in globoid cell leukodystrophy (2016) (14)
- Arabinose-derived bicyclic amino acids: synthesis, conformational analysis and construction of an αvβ3-selective RGD peptide (2002) (14)
- Substrate-Immobilized HIV-1 Tat Drives VEGFR2/&agr;v&bgr;3–Integrin Complex Formation and Polarization in Endothelial Cells (2012) (14)
- Basic fibroblast growth factor modulates in vitro differentiation of human fetal microglia. (1996) (13)
- Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions. (2010) (13)
- Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells (2009) (13)
- The adaptor protein p66shc is a positive regulator in the angiogenic response induced by hypoxic T cells (2010) (13)
- Zebrafish disease models in hematology: Highlights on biological and translational impact. (2019) (12)
- Inhibition of Angiogenesis and Tumor Growth by SCH 221153 , a Dual a v b 3 and a v b 5 Integrin Receptor Antagonist 1 (2001) (12)
- U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis (2017) (12)
- Basic fibroblast growth factor bound to cell substrate promotes cell adhesion, proliferation, and protease production in cultured endothelial cells. (1992) (12)
- CEACAM1/VEGF cross‐talk during neuroblastic tumour differentiation (2007) (12)
- Basic fibroblast growth factor-induced angiogenesis in the chick embryo chorioallantoic membrane: an electron microscopy study. (1997) (12)
- VEGF-Independent Activation of Müller Cells by the Vitreous from Proliferative Diabetic Retinopathy Patients (2021) (12)
- β3 Integrin Promotes Long-Lasting Activation and Polarization of Vascular Endothelial Growth Factor Receptor 2 by Immobilized Ligand (2015) (11)
- COSMOS-rice technology abrogates the biotoxic effects of municipal solid waste incinerator residues. (2016) (11)
- Vascular Endothelial Growth Factor in the Vitreous of Proliferative Diabetic Retinopathy Patients: Chasing a Hiding Prey? (2019) (11)
- FGF2-induced upregulation of DNA polymerase-δ p12 subunit in endothelial cells (2005) (11)
- Immunoreactive Basic Fibroblast Growth Factor‐Like Proteins in Chromaffin Granules (1991) (11)
- Induction of plasminogen activator activity by phorbol ester in transformed fetal bovine aortic endothelial cells. Possible independence from protein kinase C. (1989) (11)
- PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma (2019) (11)
- The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors (2014) (11)
- Purification and biological activities of an angiogenesis factor from human placenta. (1986) (11)
- PRO-ANGIOGENIC PROPERTIES OF ALTERNATIVELY ACTIVATED DENDRITIC CELLS. (2005) (11)
- Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. (2013) (11)
- Zebrafish embryo intersegmental vessels: a tool for investigating sprouting angiogenesis. (2015) (10)
- Angiogenesis: basic and clinical aspects. (2003) (10)
- Circulating microRNAs and Their Role in Multiple Myeloma (2019) (10)
- The biological basis for antiangiogenic therapy. (2000) (10)
- Tumor-initiating activity of the beta-blocker ZAMI 1305 in the liver of the female Wistar rat. (1984) (10)
- Integrin Mediates the Cell-adhesive Capacity and Biological Activity of Basic Fibroblast Growth Factor ( FGF-2 ) in Cultured Endothelial Cells (1996) (9)
- Anti-FGF 2 approaches as a strategy to compensate resistance to anti-VEGF therapy : long-pentraxin 3 as a novel antiangiogenic FGF 2-antagonist (2009) (9)
- Claudin3 is localized outside the tight junctions in human carcinomas (2018) (8)
- Synthetic Site-Selectively Mono-6-O-Sulfated Heparan Sulfate Dodecasaccharide Shows Anti-Angiogenic Properties In Vitro and Sensitizes Tumors to Cisplatin In Vivo (2016) (8)
- PRediction of infarct size by enzymatic techniques: modification of a method and clinical application. (1979) (8)
- Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. (2000) (8)
- Atypical Chemokine Receptor 3 Generates Guidance Cues for CXCL12-Mediated Endothelial Cell Migration (2019) (8)
- d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 (2020) (8)
- Upregulation of urokinase‐type plasminogen activator by endogenous and exogenous HIV‐1 Tat protein in tumour cell lines derived from BK virus/tat‐transgenic mice (1997) (8)
- Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer (2020) (8)
- Angiogenic phenotype induced by basic fibroblast growth factor transfection in brain microvascular endothelial cells. (1996) (8)
- Antiangiogenesis by chemotherapeutic agents. (2005) (7)
- Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion (2021) (7)
- Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma (2021) (7)
- Functional Domains of Basic Fibroblast Growth Factor: Possible Role of Asp‐Gly‐Arg Sequences in the Mitogenic Activity of bFGF (1991) (6)
- A Mutant of Basic Fibroblast Growth Factor that Has Lost the Ability to Stimulate Plasminogen Activator Synthesis in Endothelial Cells (1991) (6)
- Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence. (2021) (6)
- An Italian pioneer in the study of tumor angiogenesis. (2001) (6)
- The Interaction of Basic Fibroblast Growth Factor (bFGF) With Heparan Sulfate Proteoglycans (1996) (6)
- Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited anti-tumor activity. (2021) (6)
- Basic Fibroblast Growth Factor and Endothelial Cells: Receptor Interaction, Signal Transduction, Cellular Response-Dissociation of the Mitogenic Activity of bFGF from its Plasminogen Activator-Inducing Capacity (1992) (6)
- Vascular amounts and dispersion of caliber-classified vessels as key parameters to quantitate 3D micro-angioarchitectures in multiple myeloma experimental tumors (2018) (6)
- Endogenous Long Pentraxin 3 Exerts a Protective Role in a Murine Model of Pulmonary Fibrosis (2021) (6)
- Evaluation of the Biotoxicity of Tree Wood Ashes in Zebrafish Embryos. (2016) (6)
- Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. (1987) (5)
- Caffeine Inhibits Direct and Indirect Angiogenesis in Zebrafish Embryos (2021) (5)
- Thyroid modifications in male and female rats treated with the hepatocarcinogen beta-blocker ZAMI 1305. (1983) (5)
- Fibroblast Growth Factor-2 Antagonist Activity and Angiostatic Capacity of Sulfated Escherichia coli K 5 Polysaccharide Derivatives * (2001) (5)
- Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease (2019) (5)
- Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88. (2020) (5)
- Fibroblast Growth Factor-2 in Angiogenesis (2008) (5)
- Inhibition in vitro of yeast DNA polymerase I activity by beta-blockers (1982) (4)
- BASIC FIBROBLAST GROWTH-FACTOR IN HUMAN FETAL BRAIN (1990) (4)
- FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer. (2021) (4)
- Cross talk between haematopoiesis and angiogenesis. (2003) (4)
- Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver. (1984) (4)
- β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism (2020) (4)
- Long-Pentraxin 3 Affects Primary Cilium in Zebrafish Embryo and Cancer Cells via the FGF System (2020) (4)
- Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells. (2021) (4)
- Gene expression analysis identifies two distinct molecular clusters of idiopatic epiretinal membranes. (2020) (4)
- Nerve growth factor induces sphingomyelin accumulation in pheochromocytoma cells (2000) (4)
- β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease (2019) (4)
- A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis. (2020) (4)
- FGF2-induced upregulation of DNA polymerase-delta p12 subunit in endothelial cells. (2005) (4)
- The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions (2017) (4)
- Mechanisms of kaposis-sarcoma cell supernatant-induced vascular cell invasion. (1995) (3)
- Pentraxin 3 Inhibits the Angiogenic Potential of Multiple Myeloma Cells (2021) (3)
- Inhibition of DNA and RNA Synthesis in Rat Liver Nuclei by Oncogenic and Non-oncogenic β-Blockers (1985) (3)
- Erratum to Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy[ Cancer Cell (2015), 28, 225-239] (2015) (3)
- Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305. (1990) (3)
- Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma. (2021) (3)
- Involvement of αvβ3 integrin in gremlin-induced angiogenesis (2012) (3)
- THE CYSTINE-KNOT PROTEIN GREMLIN IS A NOVEL AGONIST OF THE MAJOR PRO-ANGIOGENIC RECEPTOR VEGFR2 (2010) (3)
- Biological and molecular properties of a new A v B 3 / A v B 5 integrin antagonist (2005) (3)
- Targeting Fibroblast Growth Factor/Fibroblast Growth Factor Receptor System in Angiogenesis (2007) (3)
- Human Basic Fibroblast Growth Factor: Structure-Function Relationship of an Angiogenic Molecule (1994) (3)
- Activation of the tyrosine kinase receptor is not sufficient for the full biological activity of bFGF. (1992) (3)
- Production and Biochemical Characterization of Dimeric Recombinant Gremlin-1 (2022) (3)
- In vitro inhibition of rat liver DNA polymerases α and β by β-blockers (1983) (3)
- Optical isomers of the hepatocarcinogenic beta-blocker ZAMI 1305: influence on nucleic acids synthesis and DNA integrity. (1984) (2)
- Specific Targeting of KRAS Using a Novel High-Affinity KRAS Antisense Oligonucleotide in Multiple Myeloma (2019) (2)
- Thyroid and Chemical Hepatocarcinogenesis: Further Insights from the Hepatocarcinogen Zami 1305 (1984) (2)
- Liver growth after partial hepatectomy: influence of phenobarbital administration. (1981) (2)
- morphogenic protein antagonist Drm Angiopoietin-1 mediates the proangiogenic activity of the bone (2008) (2)
- fibroblast growth factor -2 (2003) (2)
- Factor-2 Cross-Talk in Angiogenesis Osteopontin (Eta-1) and Fibroblast Growth (2003) (2)
- Zebrafish embryo as an experimental model to study tumor angiogenesis (2020) (2)
- Early liver alterations induced by the sex-dependent hepatocarcinogen beta-blocker ZAMI 1305. (1984) (2)
- Dendritic cells and angiogenesis (2008) (2)
- Nerve growth factor – endothelial cell interaction leads to angiogenesis in vitro and in vivo 1 (2002) (2)
- Recent Advances in Angiogenesis and Antiangiogenesis (2018) (2)
- Integrin Receptor Antagonist 5 β v α and 3 β v α a Dual Inhibition of Angiogenesis and Tumor Growth by SCH 221153 , Updated Version (2001) (2)
- In Situ DNA/Protein Interaction Assay to Visualize Transcriptional Factor Activation (2020) (2)
- Gullino and Angiogenesis (2002) (2)
- β-Galactosylceramidase in cancer: friend or foe? (2021) (1)
- Neutrophils3 by Activated Human - Kringle 1 Generation of Biologically Active Angiostatin (2002) (1)
- zebrafish Calcitonin receptor-like receptor guides arterial differentiation in (2008) (1)
- FGF/FGFR Axis-Blockade Leads to Anti-Tumor Activity in Waldenstrom's Macroglobulinemia By Silencing MYD88 (2020) (1)
- Inhibition of FGF-2 angiogenic activity by novel small molecules mimetic of thrombospondin-1 (TSP-1) (2012) (1)
- Prediction ofinfarct size byenzymatic techniques: modification ofamethod andclinical application (1979) (1)
- β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and Twitcher Mice (2022) (1)
- Quantification of Damageto Striated MuscleafterNormothermic or Hypothermic Ischemia (1981) (1)
- Heparin Derivatives and Semisynthetic Biotechnological Heparins as Angiogenesis Inhibitors (2005) (1)
- β-Galactosylceramidase in cancer: more than a psychosine scavenger (2022) (1)
- Editorial overview: Lymphatic vessels: More than a draining pipeline. (2018) (1)
- Liver DNA Damage by Chemical Carcinogens: Role of Thyroid Hormones (1988) (1)
- Further Studies on the Tumor-Initiating Activity of the Beta-Blocker DL-ZAMI 1305 (1986) (1)
- A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays (2015) (1)
- The role of the endothelium in globoid-cell leukodystrophy: unexpected revelations (2014) (1)
- Arabinose-Derived Bicyclic Amino Acids: Synthesis, Conformational Analysis and Construction of an αvB3-Selective RGD Peptide. (2010) (1)
- Zebrafish as a Tool to Study Tumor Angiogenesis (2009) (1)
- Simultaneously characterization of tumoral angiogenesis and vasculogenesis in Stem cell-derived teratomas. (2021) (1)
- endothelium mechanism of lymphocyte adhesion and migration across the HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel (2011) (1)
- Alternatively Activated Dendritic Cells Cutting Edge: Proangiogenic Properties of (2005) (1)
- Vascular Endothelial Growth Factor Tetrameric Tripeptide That Antagonizes Modulation of Angiogenesis by a Mechanisms of Signal Transduction : (0)
- Quantification of Tumor Vasculature by Analysis of Amount and Spatial Dispersion of Caliber-Classified Vessels. (2021) (0)
- Liver genotoxic activity of an epoxide derivative of the hepatocarcinogenic beta-blocker DL-ZAMI 1305. (1990) (0)
- Contents, Vol. 34, 1997 (1997) (0)
- development of novel small molecules mimicking thrombospondin-1 (TSP-1) antiangiogenic activity (2011) (0)
- In vivo Suppresses B 16 Melanoma Growth ) Strongly Inhibits Angiogenesis and 47-70 ( CXCL 4 L 1 / PF-4 var The COOH-Terminal Peptide of Platelet Factor-4 Variant (2010) (0)
- [Observations on the structure of the obturator nerve]. (1967) (0)
- Abstract 1235: A long pentraxin-3-derived small molecule FGF trap for the treatment of multiple myeloma (2016) (0)
- Tat Internalization and HIV-1 Long Terminal Repeat Transactivation Assays (2005) (0)
- Sunday, 18 July 2010 (2010) (0)
- Cidofovir Tumor Formation by the Acyclic Nucleoside Phosphonate Inhibition of Fibroblast Growth Factor-2-induced Vascular Updated (2001) (0)
- Fibroblast Growth Factors (2020) (0)
- Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR (2012) (0)
- [OBSERVATIONS ON THE STRUCTURE OF THE INFERIOR LARYNGEAL NERVE IN THE HUMAN FETUS AT TERM]. (1963) (0)
- VEGFR2 RECRUITMENT AND ACTIVATION BY SUBSTRATE-IMMOBILIZED DRM/GREMLIN (2010) (0)
- Cytokine Group Box-1 Protein Is a Proangiogenic Cutting Edge : Extracellular High Mobility and (2005) (0)
- Interaction between bFGF and an integrin-like molecule in Endothelial cells (EC) (1990) (0)
- Purification froma HumanHepatoma CellLineofa Basic Fibroblast GrowthFactor-Like Molecule ThatStimulates Capillary Endothelial CellPlasminogen Activator Production, DNA Synthesis, andMigration (1986) (0)
- 182 Effect of chemotherapy on human tumor xenografts differently expressing vascular endothelial growth factor (VEGF) and fibroblast growth factor-2 (FGF-2) (2004) (0)
- This information is current as 3 by Activated Human Neutrophils − Kringle 1 Generation of Biologically Active Angiostatin (2002) (0)
- Involvement of N-formyl peptide receptors in modulating the pro-angiogenic/pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (PDR) (2017) (0)
- Quantificationof Damageto StriatedMuscleafter Normothermicor HypothermicIschemia (2004) (0)
- Sphingosine-1-phosphate receptor1 (S1P1) regulates venous vascular permeability via EphB4 receptor (2011) (0)
- [On the behavior of the valate papillae and the foliate papillae after section of the glossopharyngeal and lingual nerves in the rabbit. Preliminary note]. (1962) (0)
- [THE PRIMARY CORDS OF THE BRACHIAL PLEXUS IN THE FETUS AND ADULT: STRUCTURAL ASPECTS AND PRACTICAL CORRELATIONS WITH THE ANTERIOR SCALENUS SYNDROME]. (1963) (0)
- [1st observations on the composition of the vagus nerve of the fetus at term]. (1962) (0)
- Abstract A039: FGF/PTX3 crosstalk in bladder cancer: novel prognostic and therapeutic implications (2018) (0)
- The Urokinase Receptor-Derived Peptide UPARANT Inhibits Pathological Retinal Angiogenesis (2014) (0)
- FGF Ligand Traps for the Therapy of FGF-Dependent Tumors (2017) (0)
- Conference Abstracts of the 8th International Meeting on "Angiogenesis: Basic Science and Clinical Applications," Corfu, Greece, 29 June to 3 July (2006) (0)
- Meeting Report The biological basis for antiangiogenic therapy (2000) (0)
- [Clinico-statistical considerations on 398 cases of gastroduodenal hemorrhage]. (1963) (0)
- [Considerations on the pathogenesis of echinococcal cysts of the pelvic cavity and ischio-rectal cavity]. (1966) (0)
- Urokinase activity and mobilization in coronary post-capillary endothelial cells exposed to nitric oxide (1995) (0)
- VEGFR2 recruitment and activation by substratum-immobilized gremlin (2012) (0)
- Is the Beta-Blocker DL-ZAMI 1305 a Tumor Promoter for Rat Liver? (1991) (0)
- Long-Pentraxin 3 Derivativ e as a Small-Molecule FGF Trap for Cancer Therapy Graphical (2015) (0)
- Abstract C4: TR-764 is a novel tubulin binding agent with strong antiangiogenic activity. (2013) (0)
- The zebrafish knockdown of galactocerebrosidase contributes to understand the human Krabbe Disease (2011) (0)
- CytokineBox-1 Protein Is a Proangiogenic Cutting Edge: Extracellular High Mobility (2012) (0)
- Subject Index, Vol. 34, 1997 (1997) (0)
- The natural FGF-trap long pentraxin 3 inhibits lymphangiogenesis and lymphatic dissemination (2022) (0)
- Vascular and Stromal Contributions to Tumor Bone-Homing: Focus on Multiple Myeloma (2020) (0)
- TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis (2013) (0)
- Interaction of Angiogenic Growth Factors with Endothelial Cell Heparan Sulfate Proteoglycans: Implications for the Development of Angiostatic Compounds (2001) (0)
- Autocrine Role of Basic Fibroblast Growth Factor (bFGF) in Angiogenesis and Angioproliferative Diseases (1998) (0)
- New insights in the modulation of tumor angiogenesis. (2009) (0)
- Overcoming the Supportive Stroma-Induced Proliferation in Waldenstrom's Macroglobulinemia By Selective Inhibition of the FGF/FGF-Receptor Axis (2019) (0)
- [Study of the modifications of plasma lipids and serum proteins in subjects with normo- and hyperfunctioning goiter treated surgically]. (1962) (0)
- Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer (2023) (0)
- - 1-Thrombospondin-1 as a scavenger for matrix-associated fibroblast growth factor-2 (2003) (0)
- N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors (2017) (0)
- Modulation of GJIC in endothelial cells: Possible role of PKC activation (1990) (0)
- Assay of succinate-cytochrome c reductase in human brain. (1985) (0)
- The BMP antagonist DRM supports angiogenesis and tumor proression (2009) (0)
- , Cells In Vitro and Neointima Formation In Vivo Dependent Activation of Smooth Muscle − Pentraxin 3 Inhibits Fibroblast Growth Factor 2 (2005) (0)
- Interaction of Angiogenic Growth Factors with Endothelial Cell Heparan Sulfate Proteoglycans (2002) (0)
- Basic Fibroblast Growth Factor Expression in Endothelial Cells: An Autocrine Role in Angiogenesis? (1996) (0)
- FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 (2010) (0)
- Osteopontin induces a pro-angiogenic program in human monocytes through a mechanism mediated by interleukin-1 (2006) (0)
- Proprietà pro-angiogeniche delle cellule dendritiche alternativamente attivate (2005) (0)
- Oncosuppressive and oncogenic activity of the sphingolipid-metabolizing enzyme β-galactosylceramidase. (2021) (0)
- Basic fibroblast growth factor and endothelial cells: receptor interaction, signal transduction, cellular response” in Angiogenesis in Health and Disease (1992) (0)
- The Italian ‘Special Project on Angiogenesis’ (2004) (0)
- [FURTHER OBSERVATIONS ON THE COMPOSITION OF THE VAGUS NERVE IN THE HUMAN FETUS AT TERM. RESEARCH ON THORACIC SEGMENT]. (1963) (0)
- [ON THE NATURE OF THE FIBERS CONSTITUTING THE HYPOGLOSSAL NERVE IN THE HUMAN FETUS AT TERM]. (1963) (0)
- 3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy (2017) (0)
- The distal type of hereditary motor neuropathy. Clinical and neurophysiological report of a dominant case. (1990) (0)
- Abstract C121: Long Pentraxin-3 modulates bladder cancer progression (2019) (0)
- Abstract 178: Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis (2014) (0)
- Cross-talk among brain cells: role of basic fibroblast growth factor in human development (1998) (0)
- VEGFR2 recruitment and activation by substrate-immobilized VEGF (2009) (0)
- Comparative 3d-Morphometry of the Microvascular Unit In Tumors and Normal Tissues: Quantitative Studies on Corrosion Casts (1999) (0)
- [Structural aspects of the ischiatic nerve. Preliminary note]. (1967) (0)
- PTX3 inhibits angiogenesis Selective recognition of fibroblast growth factor-2 by the long pentraxin (2013) (0)
- [CONTRIBUTION TO THE STUDY OF ECHINOCOCCAL CYSTS OF THE PELVIC EXCAVATION]. (1963) (0)
- Abstract B134: Inhibition of the fibroblast growth factor system by a new FGF trap induces oxidative stress and mitochondrial apoptosis in multiple myeloma cells (2018) (0)
- Sodium nitroprusside stimulates mobilization and urokinase activity in coronary post-capillary endothelial cells (1995) (0)
- Polymerase I Activity by Beta-blockers (2005) (0)
- In vitro and ex vivo retina angiogenesis assays (2013) (0)
- Zebra-Sphinx: Modeling Sphingolipidoses in Zebrafish (2023) (0)
- List of contributors (2020) (0)
- Inactive VEGFR2(R1032Q) exerts pro‐oncogenic activity through heterodimerization with wild‐type receptor (2021) (0)
- [Tumors of the broad ligament of the uterus in relation to inguinal hernias. (Presentation of a case)]. (1966) (0)
- FGF trapping impairs multiple myeloma growth through c-Myc degradation-induced mitochondrial oxidative stress (2019) (0)
- angiogenesisexpression of inflammatory cytokines before Angiopoietin-1 and vascular endothelial growth factor (2015) (0)
- Development of oligosaccharides as anti-angiogenic agents (2005) (0)
- resveratrol stereoisomers Integrin-dependent antiangiogenic activity of 3 β v α Updated (2008) (0)
- Abstract C052: FGF trapping impairs multiple myeloma growth through c-Myc degradation-induced mitochondrial oxidative stress (2019) (0)
- 45th Annual Meeting of the Italian Cancer Society Bergamo, 9-12 November 2003 (2004) (0)
- [Research on the blood concentration of lactoflavin in subjects with norm- and hyperfunctioning goiter before and after subtotal thyroid resection]. (1962) (0)
- Involvement of the adaptor protein p66Shc and hypoxia inducible factor (HIF)-1 in the induction of angiogenesis by T cells. (2010) (0)
- Mutants of basic fibroblast growth factor with altered biological properties (1990) (0)
- [Structural aspects of the radial and median nerves]. (1967) (0)
- Inhibition of protein synthesis in ischaemic liver from phenobarbitone-treated rat (1979) (0)
- Vascular amounts and dispersion of caliber-classified vessels as key parameters to quantitate 3D micro-angioarchitectures in multiple myeloma experimental tumors (2018) (0)
- Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease (2015) (0)
- 307 Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Marco Presta?
Marco Presta is affiliated with the following schools:
